Moreover, GASC1 inhibition may provide a much-needed treatment option for tumors that stably express ROCK2, as well as other antiapoptotic BCL2 family members that mediate resistance to liver cancer chemotherapy. The gene discussed is ROCK2; the disease is liver cancer.